BNP Paribas Arbitrage, SA
- SEC CIK
- 0001166588
- Latest filing
- Aug 13, 2026
VTGN holding history
Vistagen Therapeutics, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 6
- Value
- $1
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6 | $1 | <0.1% | −7−53.8% | Reduced | Holders |
| Q1 2026 | 13 | $7 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 13 | $9 | <0.1% | −43−76.8% | Reduced | Holders |
| Q3 2025 | 56 | $199 | <0.1% | −422−88.3% | Reduced | Holders |
| Q2 2025 | 478 | $956 | <0.1% | +7+1.5% | Added | Holders |
| Q1 2025 | 471 | $1.18K | <0.1% | −2−0.4% | Reduced | Holders |
| Q4 2024 | 473 | $1.40K | <0.1% | +473 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −3,207−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q1 2023 | 96,200 | $12.0K | <0.1% | +56,259+140.9% | Added | Holders |
| Q4 2022 | 39,941 | $4.11K | <0.1% | −29,314−42.3% | Reduced | Holders |
| Q3 2022 | 69,255 | $10.5K | <0.1% | +25,162+57.1% | Added | Holders |
| Q2 2022 | 44,093 | $38.8K | <0.1% | +27,057+158.8% | Added | Holders |
| Q1 2022 | 17,036 | $21.1K | <0.1% | −24,500−59.0% | Reduced | Holders |
| Q4 2021 | 41,536 | $81.0K | <0.1% | +6,531+18.7% | Added | Holders |
| Q3 2021 | 35,005 | $95.9K | <0.1% | +27,637+375.1% | Added | Holders |
| Q2 2021 | 7,368 | $23.2K | <0.1% | +7,368 | New | Holders |